Instructions from Tianjian Certified Public Accountants (Special General Partnership) on financial matters in the review inquiry letter of Orient Pharmaceutical Co., Ltd.'s application documents for the issuance of convertible corporate bonds to unspecified targets (2023 financial data update version)

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.

天健会计师事务所（特殊普通合伙）关于奥锐特药业股份有限公司向不特定对象发行可转换公司债券申请文件的审核问询函中有关财务事项的说明（2023年年度财务数据更新版）

Risk Disclaimer

Statement